aluates Reports

$ 0.0

Automative

Global Acute Sinusitis Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-38M5730

Global Acute Sinusitis Market Insights Forecast to 2028

BUY CHAPTERS

Global Acute Sinusitis Market Research Report 2025

Code: QYRE-Auto-38M5730

Report

July 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Teva Pharmaceutical

Sun Pharmaceutical

Sanofi

Pfizer Inc

Novartis

Merck

Johnson & Johnson

Fresenius Kabi

Eli Lilly and Company

Dr. Reddy’s Laboratories

Bristol–Myers Squibb

Bionorica

Bayer

Astrazeneca plc

Amgen Inc

Abbott

Acute Sinusitis Market

The global market for Acute Sinusitis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Acute sinusitis, also called acute rhinosinusitis, is a short-term inflammation of the membranes that line your nose and surrounding sinuses.

North American market for Acute Sinusitis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Acute Sinusitis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Acute Sinusitis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Acute Sinusitis include Teva Pharmaceutical, Sun Pharmaceutical, Sanofi, Pfizer, Novartis, Merck, Johnson & Johnson, Fresenius Kabi, Eli Lilly and Company, Dr. Reddy's Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Acute Sinusitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Sinusitis.

The Acute Sinusitis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acute Sinusitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Sinusitis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acute Sinusitis Market Report

Report Metric	Details
Report Name	Acute Sinusitis Market
Segment by Type	OTC Pain Relievers Saline Nasal Spray Nasal Corticosteroids Others
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva Pharmaceutical, Sun Pharmaceutical, Sanofi, Pfizer, Novartis, Merck, Johnson & Johnson, Fresenius Kabi, Eli Lilly and Company, Dr. Reddy's Laboratories, Bristol-Myers Squibb, Bionorica, Bayer, AstraZeneca, Amgen, Abbott
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Sinusitis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acute Sinusitis Market report?

Ans: The main players in the Acute Sinusitis Market are Teva Pharmaceutical, Sun Pharmaceutical, Sanofi, Pfizer, Novartis, Merck, Johnson & Johnson, Fresenius Kabi, Eli Lilly and Company, Dr. Reddy's Laboratories, Bristol-Myers Squibb, Bionorica, Bayer, AstraZeneca, Amgen, Abbott

What are the Application segmentation covered in the Acute Sinusitis Market report?

Ans: The Applications covered in the Acute Sinusitis Market report are Hospital, Clinic

What are the Type segmentation covered in the Acute Sinusitis Market report?

Ans: The Types covered in the Acute Sinusitis Market report are OTC Pain Relievers, Saline Nasal Spray, Nasal Corticosteroids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Sinusitis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 OTC Pain Relievers

1.2.3 Saline Nasal Spray

1.2.4 Nasal Corticosteroids

1.2.5 Others

1.3 Market by Application

1.3.1 Global Acute Sinusitis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acute Sinusitis Market Perspective (2020-2031)

2.2 Global Acute Sinusitis Growth Trends by Region

2.2.1 Global Acute Sinusitis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Acute Sinusitis Historic Market Size by Region (2020-2025)

2.2.3 Acute Sinusitis Forecasted Market Size by Region (2026-2031)

2.3 Acute Sinusitis Market Dynamics

2.3.1 Acute Sinusitis Industry Trends

2.3.2 Acute Sinusitis Market Drivers

2.3.3 Acute Sinusitis Market Challenges

2.3.4 Acute Sinusitis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acute Sinusitis Players by Revenue

3.1.1 Global Top Acute Sinusitis Players by Revenue (2020-2025)

3.1.2 Global Acute Sinusitis Revenue Market Share by Players (2020-2025)

3.2 Global Acute Sinusitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Acute Sinusitis Revenue

3.4 Global Acute Sinusitis Market Concentration Ratio

3.4.1 Global Acute Sinusitis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Sinusitis Revenue in 2024

3.5 Global Key Players of Acute Sinusitis Head office and Area Served

3.6 Global Key Players of Acute Sinusitis, Product and Application

3.7 Global Key Players of Acute Sinusitis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Sinusitis Breakdown Data by Type

4.1 Global Acute Sinusitis Historic Market Size by Type (2020-2025)

4.2 Global Acute Sinusitis Forecasted Market Size by Type (2026-2031)

5 Acute Sinusitis Breakdown Data by Application

5.1 Global Acute Sinusitis Historic Market Size by Application (2020-2025)

5.2 Global Acute Sinusitis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Acute Sinusitis Market Size (2020-2031)

6.2 North America Acute Sinusitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Acute Sinusitis Market Size by Country (2020-2025)

6.4 North America Acute Sinusitis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acute Sinusitis Market Size (2020-2031)

7.2 Europe Acute Sinusitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Acute Sinusitis Market Size by Country (2020-2025)

7.4 Europe Acute Sinusitis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acute Sinusitis Market Size (2020-2031)

8.2 Asia-Pacific Acute Sinusitis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Acute Sinusitis Market Size by Region (2020-2025)

8.4 Asia-Pacific Acute Sinusitis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acute Sinusitis Market Size (2020-2031)

9.2 Latin America Acute Sinusitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Acute Sinusitis Market Size by Country (2020-2025)

9.4 Latin America Acute Sinusitis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acute Sinusitis Market Size (2020-2031)

10.2 Middle East & Africa Acute Sinusitis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Acute Sinusitis Market Size by Country (2020-2025)

10.4 Middle East & Africa Acute Sinusitis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva Pharmaceutical

11.1.1 Teva Pharmaceutical Company Details

11.1.2 Teva Pharmaceutical Business Overview

11.1.3 Teva Pharmaceutical Acute Sinusitis Introduction

11.1.4 Teva Pharmaceutical Revenue in Acute Sinusitis Business (2020-2025)

11.1.5 Teva Pharmaceutical Recent Development

11.2 Sun Pharmaceutical

11.2.1 Sun Pharmaceutical Company Details

11.2.2 Sun Pharmaceutical Business Overview

11.2.3 Sun Pharmaceutical Acute Sinusitis Introduction

11.2.4 Sun Pharmaceutical Revenue in Acute Sinusitis Business (2020-2025)

11.2.5 Sun Pharmaceutical Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Acute Sinusitis Introduction

11.3.4 Sanofi Revenue in Acute Sinusitis Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Acute Sinusitis Introduction

11.4.4 Pfizer Revenue in Acute Sinusitis Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Acute Sinusitis Introduction

11.5.4 Novartis Revenue in Acute Sinusitis Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Acute Sinusitis Introduction

11.6.4 Merck Revenue in Acute Sinusitis Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Acute Sinusitis Introduction

11.7.4 Johnson & Johnson Revenue in Acute Sinusitis Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Fresenius Kabi

11.8.1 Fresenius Kabi Company Details

11.8.2 Fresenius Kabi Business Overview

11.8.3 Fresenius Kabi Acute Sinusitis Introduction

11.8.4 Fresenius Kabi Revenue in Acute Sinusitis Business (2020-2025)

11.8.5 Fresenius Kabi Recent Development

11.9 Eli Lilly and Company

11.9.1 Eli Lilly and Company Company Details

11.9.2 Eli Lilly and Company Business Overview

11.9.3 Eli Lilly and Company Acute Sinusitis Introduction

11.9.4 Eli Lilly and Company Revenue in Acute Sinusitis Business (2020-2025)

11.9.5 Eli Lilly and Company Recent Development

11.10 Dr. Reddy's Laboratories

11.10.1 Dr. Reddy's Laboratories Company Details

11.10.2 Dr. Reddy's Laboratories Business Overview

11.10.3 Dr. Reddy's Laboratories Acute Sinusitis Introduction

11.10.4 Dr. Reddy's Laboratories Revenue in Acute Sinusitis Business (2020-2025)

11.10.5 Dr. Reddy's Laboratories Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Details

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Acute Sinusitis Introduction

11.11.4 Bristol-Myers Squibb Revenue in Acute Sinusitis Business (2020-2025)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Bionorica

11.12.1 Bionorica Company Details

11.12.2 Bionorica Business Overview

11.12.3 Bionorica Acute Sinusitis Introduction

11.12.4 Bionorica Revenue in Acute Sinusitis Business (2020-2025)

11.12.5 Bionorica Recent Development

11.13 Bayer

11.13.1 Bayer Company Details

11.13.2 Bayer Business Overview

11.13.3 Bayer Acute Sinusitis Introduction

11.13.4 Bayer Revenue in Acute Sinusitis Business (2020-2025)

11.13.5 Bayer Recent Development

11.14 AstraZeneca

11.14.1 AstraZeneca Company Details

11.14.2 AstraZeneca Business Overview

11.14.3 AstraZeneca Acute Sinusitis Introduction

11.14.4 AstraZeneca Revenue in Acute Sinusitis Business (2020-2025)

11.14.5 AstraZeneca Recent Development

11.15 Amgen

11.15.1 Amgen Company Details

11.15.2 Amgen Business Overview

11.15.3 Amgen Acute Sinusitis Introduction

11.15.4 Amgen Revenue in Acute Sinusitis Business (2020-2025)

11.15.5 Amgen Recent Development

11.16 Abbott

11.16.1 Abbott Company Details

11.16.2 Abbott Business Overview

11.16.3 Abbott Acute Sinusitis Introduction

11.16.4 Abbott Revenue in Acute Sinusitis Business (2020-2025)

11.16.5 Abbott Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical

Sun Pharmaceutical

Sanofi

Pfizer Inc

Novartis

Merck

Johnson & Johnson

Fresenius Kabi

Eli Lilly and Company

Dr. Reddy’s Laboratories

Bristol–Myers Squibb

Bionorica

Bayer

Astrazeneca plc

Amgen Inc

Abbott

List of Tables

Table 1. Global Acute Sinusitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of OTC Pain Relievers

Table 3. Key Players of Saline Nasal Spray

Table 4. Key Players of Nasal Corticosteroids

Table 5. Key Players of Others

Table 6. Global Acute Sinusitis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Acute Sinusitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Acute Sinusitis Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Acute Sinusitis Market Share by Region (2020-2025)

Table 10. Global Acute Sinusitis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Acute Sinusitis Market Share by Region (2026-2031)

Table 12. Acute Sinusitis Market Trends

Table 13. Acute Sinusitis Market Drivers

Table 14. Acute Sinusitis Market Challenges

Table 15. Acute Sinusitis Market Restraints

Table 16. Global Acute Sinusitis Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Acute Sinusitis Market Share by Players (2020-2025)

Table 18. Global Top Acute Sinusitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Sinusitis as of 2024)

Table 19. Ranking of Global Top Acute Sinusitis Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Acute Sinusitis Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Acute Sinusitis, Headquarters and Area Served

Table 22. Global Key Players of Acute Sinusitis, Product and Application

Table 23. Global Key Players of Acute Sinusitis, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Acute Sinusitis Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Acute Sinusitis Revenue Market Share by Type (2020-2025)

Table 27. Global Acute Sinusitis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Acute Sinusitis Revenue Market Share by Type (2026-2031)

Table 29. Global Acute Sinusitis Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Acute Sinusitis Revenue Market Share by Application (2020-2025)

Table 31. Global Acute Sinusitis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Acute Sinusitis Revenue Market Share by Application (2026-2031)

Table 33. North America Acute Sinusitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Acute Sinusitis Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Acute Sinusitis Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Acute Sinusitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Acute Sinusitis Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Acute Sinusitis Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Acute Sinusitis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Acute Sinusitis Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Acute Sinusitis Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Acute Sinusitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Acute Sinusitis Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Acute Sinusitis Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Acute Sinusitis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Acute Sinusitis Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Acute Sinusitis Market Size by Country (2026-2031) & (US$ Million)

Table 48. Teva Pharmaceutical Company Details

Table 49. Teva Pharmaceutical Business Overview

Table 50. Teva Pharmaceutical Acute Sinusitis Product

Table 51. Teva Pharmaceutical Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 52. Teva Pharmaceutical Recent Development

Table 53. Sun Pharmaceutical Company Details

Table 54. Sun Pharmaceutical Business Overview

Table 55. Sun Pharmaceutical Acute Sinusitis Product

Table 56. Sun Pharmaceutical Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 57. Sun Pharmaceutical Recent Development

Table 58. Sanofi Company Details

Table 59. Sanofi Business Overview

Table 60. Sanofi Acute Sinusitis Product

Table 61. Sanofi Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 62. Sanofi Recent Development

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Acute Sinusitis Product

Table 66. Pfizer Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 67. Pfizer Recent Development

Table 68. Novartis Company Details

Table 69. Novartis Business Overview

Table 70. Novartis Acute Sinusitis Product

Table 71. Novartis Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 72. Novartis Recent Development

Table 73. Merck Company Details

Table 74. Merck Business Overview

Table 75. Merck Acute Sinusitis Product

Table 76. Merck Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 77. Merck Recent Development

Table 78. Johnson & Johnson Company Details

Table 79. Johnson & Johnson Business Overview

Table 80. Johnson & Johnson Acute Sinusitis Product

Table 81. Johnson & Johnson Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 82. Johnson & Johnson Recent Development

Table 83. Fresenius Kabi Company Details

Table 84. Fresenius Kabi Business Overview

Table 85. Fresenius Kabi Acute Sinusitis Product

Table 86. Fresenius Kabi Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 87. Fresenius Kabi Recent Development

Table 88. Eli Lilly and Company Company Details

Table 89. Eli Lilly and Company Business Overview

Table 90. Eli Lilly and Company Acute Sinusitis Product

Table 91. Eli Lilly and Company Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 92. Eli Lilly and Company Recent Development

Table 93. Dr. Reddy's Laboratories Company Details

Table 94. Dr. Reddy's Laboratories Business Overview

Table 95. Dr. Reddy's Laboratories Acute Sinusitis Product

Table 96. Dr. Reddy's Laboratories Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 97. Dr. Reddy's Laboratories Recent Development

Table 98. Bristol-Myers Squibb Company Details

Table 99. Bristol-Myers Squibb Business Overview

Table 100. Bristol-Myers Squibb Acute Sinusitis Product

Table 101. Bristol-Myers Squibb Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 102. Bristol-Myers Squibb Recent Development

Table 103. Bionorica Company Details

Table 104. Bionorica Business Overview

Table 105. Bionorica Acute Sinusitis Product

Table 106. Bionorica Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 107. Bionorica Recent Development

Table 108. Bayer Company Details

Table 109. Bayer Business Overview

Table 110. Bayer Acute Sinusitis Product

Table 111. Bayer Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 112. Bayer Recent Development

Table 113. AstraZeneca Company Details

Table 114. AstraZeneca Business Overview

Table 115. AstraZeneca Acute Sinusitis Product

Table 116. AstraZeneca Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 117. AstraZeneca Recent Development

Table 118. Amgen Company Details

Table 119. Amgen Business Overview

Table 120. Amgen Acute Sinusitis Product

Table 121. Amgen Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 122. Amgen Recent Development

Table 123. Abbott Company Details

Table 124. Abbott Business Overview

Table 125. Abbott Acute Sinusitis Product

Table 126. Abbott Revenue in Acute Sinusitis Business (2020-2025) & (US$ Million)

Table 127. Abbott Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Acute Sinusitis Picture

Figure 2. Global Acute Sinusitis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acute Sinusitis Market Share by Type: 2024 VS 2031

Figure 4. OTC Pain Relievers Features

Figure 5. Saline Nasal Spray Features

Figure 6. Nasal Corticosteroids Features

Figure 7. Others Features

Figure 8. Global Acute Sinusitis Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Acute Sinusitis Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Acute Sinusitis Report Years Considered

Figure 13. Global Acute Sinusitis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Acute Sinusitis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Acute Sinusitis Market Share by Region: 2024 VS 2031

Figure 16. Global Acute Sinusitis Market Share by Players in 2024

Figure 17. Global Top Acute Sinusitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Sinusitis as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Acute Sinusitis Revenue in 2024

Figure 19. North America Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Acute Sinusitis Market Share by Country (2020-2031)

Figure 21. United States Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Acute Sinusitis Market Share by Country (2020-2031)

Figure 25. Germany Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Acute Sinusitis Market Share by Region (2020-2031)

Figure 33. China Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Acute Sinusitis Market Share by Country (2020-2031)

Figure 41. Mexico Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Acute Sinusitis Market Share by Country (2020-2031)

Figure 45. Turkey Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Acute Sinusitis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Teva Pharmaceutical Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 49. Sun Pharmaceutical Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 50. Sanofi Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 55. Fresenius Kabi Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 56. Eli Lilly and Company Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 57. Dr. Reddy's Laboratories Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 59. Bionorica Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 60. Bayer Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 61. AstraZeneca Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 62. Amgen Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 63. Abbott Revenue Growth Rate in Acute Sinusitis Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sinusitis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Viral Rhinosinusitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sinusitis Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs For Sinusitis Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Rhinosinusitis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Allergy Sinus Nasal Spray Market Research Report 2024

Global Allergy and Sinus Medicine Market Research Report 2025

Global Rhinoconjunctivitis Market Research Report 2024

Global Sinuscope Endoscopes Market Research Report 2024

Global Allergy and Sinus Relief Market Research Report 2024

Global Sinus Irrigation System Market Research Report 2024

Global Sinus Endoscope Market Research Report 2025

Global Intranasal Corticosteroids Market Research Report 2024

Sinus Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sinusitis Medical Treatment Market Research Report 2024

Global Pediatric Chronic Rhinosinusitis Treatment Market Research Report 2024

Global Sinusitis Treatment Medication Market Research Report 2024

Global Nasal Sprays Market Insights Forecast to 2030

Global Inflammatory Eye Diseases Treatment Market Research Report 2025

RELATED REPORTS

Global Vertigo Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11L6252

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Meniere’s Disease Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33J5784

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Global Sinusitis Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30H5826

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Global Sinusitis Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30R5827

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions